Pathstone Family Office, LLC Codiak Bio Sciences, Inc. Transaction History

Pathstone Family Office, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.18 - $0.81 $360 - $1,620	2,000 Added 13.33%	17,000 $3,000
Q4 2022 Oct 23, 2023	BUY	$0.32 - $0.9 $960 - $2,700	3,000 Added 25.0%	15,000 $6,000
Q4 2022 Feb 13, 2023	BUY	$0.32 - $0.9 $960 - $2,700	3,000 Added 25.0%	15,000 $6,000
Q3 2022 Oct 23, 2023	BUY	$0.82 - $3.19 $1,640 - $6,380	2,000 Added 20.0%	12,000 $10,000
Q3 2022 Nov 14, 2022	BUY	$0.82 - $3.19 $1,640 - $6,380	2,000 Added 20.0%	12,000 $9,000
Q2 2022 Oct 23, 2023	BUY	$2.24 - $6.96 $22,400 - $69,600	10,000 New	10,000 $28,000
Q2 2022 Aug 15, 2022	BUY	$2.24 - $6.96 $22,400 - $69,600	10,000 New	10,000 $29,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Pathstone Family Office, LLC, based on Form 13F filings with the SEC.

Stay updated on Pathstone Family Office, LLC with notifications on news.